Industry Leaders Tara Maddala and Allison Ryan Join Delfi Diagnostics Leadership Team
News provided by
Share this article
Share this article
BALTIMORE, Feb. 17, 2021 /PRNewswire/ Delfi Diagnostics, a pioneering developer of a new class of high performance, affordable liquid biopsy tests for early cancer detection, has hired Tara Maddala as Vice President of Clinical Development and Allison Ryan as Vice President of Data Science. They each will be responsible for establishing critical new functions within the company as it works to develop and commercialize Delfi s cancer screening blood tests. From our first conversations, it was obvious that Tara and Allison are both committed to putting science first, and care about radically improving outcomes for anyone who could be affected by cancer, said Delfi s Chief Operating Officer Jenn Buechel. It is also clear that they are inspiring leaders with a deep commitment to serving their teams and organizations. We are excited to wel